Dudediligence.

Pasithea Therapeutics Corp

KTTANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$3.0MSep ’24−$3.2MDec ’24−$3.6MMar ’25−$3.7MJun ’25−$3.0MSep ’25−$10.1MDec ’25−$2.9MMar ’26−$5.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$15,062$486,559none on filenone on filenone on file
Gross profit−$2,213$373,364none on filenone on filenone on file
Operating income−$4.5M−$12.6M−$16.0M−$14.2M−$20.9M
Net income−$2.2M−$13.9M−$16.0M−$13.9M−$20.4M
Operating cash flow−$3.2M−$11.9M−$12.8M−$13.9M−$15.2M
Free cash flow−$3.2M−$12.0M−$12.8Mnone on filenone on file
Cash$53.0M$33.1M$16.3M$6.9M$55.2M
Shares outstanding23.0M1.3M1.0M1.4M23.1M